Bank of Jackson Hole Trust’s AstraZeneca AZN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-56
Closed -$10.2K 520
2025
Q4
$10.2K Buy
56
+16
+40% +$2.81K ﹤0.01% 392
2025
Q3
$6.14K Hold
40
﹤0.01% 396
2025
Q2
$5.59K Hold
40
﹤0.01% 405
2025
Q1
$6.1K Hold
40
﹤0.01% 401
2024
Q4
$5.24K Buy
+40
New +$5.6K ﹤0.01% 416

Other funds holding AZN

Bank of Jackson Hole Trust's AZN Position: Q1 2026 in Review

Bank of Jackson Hole Trust sold out of AstraZeneca (AZN) in Q1 2026, closing a stake of 56 shares — an estimated $10.2K sold.

Bank of Jackson Hole Trust first reported a position in AZN in Q4 2024 and held it in 5 quarters. The position peaked at $10.2K in Q4 2025. 1,383 funds tracked by Wall St. Rank hold AZN as of Q1 2026.

  • Bank of Jackson Hole Trust reported no remaining AstraZeneca position as of Q1 2026 after selling out during the quarter.
  • Bank of Jackson Hole Trust sold 56 AstraZeneca shares in Q1 2026, an estimated $10.2K.
  • Bank of Jackson Hole Trust first reported a position in AstraZeneca in Q4 2024 and held it in 5 quarters.
  • Bank of Jackson Hole Trust's AstraZeneca position peaked at $10.2K in Q4 2025.
  • 1,383 funds tracked by Wall St. Rank held AstraZeneca as of Q1 2026.

Based on Bank of Jackson Hole Trust's 13F filing for Q1 2026, filed 12 May 2026.